A recent Wipro and UMB Techweb study highlighted an emerging trend in the Pharma and Life Sciences domain - the growing popularity of developing markets as clinical test sites. This trend has arisen due to factors, such as faster time to market, lower R&D costs etc.
Assisting this trend and lowering clinical trial costs further is the cloud computing phenomenon. The cost of transferring data and findings to and from the company and the trial site is a major component of the total trial cost. In cases of trials that involve substantial data crunching, data updates made in one location can be accessed in real time across diverse regions through the cloud, bringing down data processing costs significantly. Another area where cloud computing can help is driving collaboration and interactions between the sponsors, research partners, patients and all others involved in clinical trials. It is therefore no surprise that our study revealed that several companies are exploring the potential of cloud computing to provide a centralized and globally accessible warehouse of data.
However, the practice of integrating cloud into clinical trials is still in the nascent stage and the pharma sector could greatly benefit from the assistance of an external partner with cloud expertise. Offerings like Wipro's Rapid Trials Platform, an open standards-based platform for business process integration across the drug development life cycle can help companies leverage cloud computing to their best advantage in conducting clinical trials.
With the right impetus, the interconnectivity and pace provided by cloud computing can definitely make emerging markets the most favored destinations for clinical trials. This opens up a world of opportunity for the health care sector in India. What do you think of the possibilities? Do you plan to use cloud computing in your global clinical trials? Do you anticipate any challenges in harnessing the cloud? We'd love to hear your insights on this!